Mechanism & significance
What changes in the microbe, and why
- Marco and colleagues synthesized Rh(III) and Ir(III) half-sandwich compounds with a chelating phenylbenzimidazole ligand. Attaching valproate changed antibacterial activity against Enterococcus faecium and Staphylococcus aureus. The comparison identifies a structure–activity relationship within that chemical family; it does not assign the result to free valproate, free rhodium, or a combination of separately administered substances. [1]
- A second program studied RhCp* complexes with a bidentate ligand and a releasable nitrogen-donor ligand. Selected econazole-containing combinations gained E. coli activity despite inactive separate components; other combinations inhibited MRSA. Solution-equilibrium measurements accompanied the susceptibility tests. [2]
- A broader carbohydrate-ligand screen found rhodium complexes less active than the osmium and ruthenium members of the tested families. Several organisms were not susceptible at all. That within-series comparison cautions against assuming that replacing a metal center preserves activity, even when ligands are related. [3]
The broader picture
Rhodium is being investigated through engineered coordination compounds whose ligands are part of the biological intervention. Two instructive approaches are valproate conjugation and exchangeable nitrogen-donor ligands. Both concern laboratory compound development. Neither demonstrates that exposure to rhodium alone produces the same effect or that a successful bacterial assay predicts a useful treatment. [1][2][3]
Experiments worth knowing
S. aureus and E. faecium cultures
Changing the conjugated ligand
Study design. Valproate conjugates compared within a half-sandwich organometallic series.
What they found. Conjugation changed antibacterial activity. [1]
How to read it. The active entity is the chemically defined conjugate.
Sensitive and resistant bacterial strains
Chemistry alongside susceptibility
Study design. Controlled-pH assays of mixed-ligand complexes.
What they found. Selected combinations broadened activity. [2]
How to read it. Speciation and selectivity require further testing.
Community & host evidence
The bacterial experiments concern reference strains and resistant isolates, not an intact microbial community. Changes in the outer ligand can alter which organisms respond, so activity against a Gram-positive isolate should not be described as broad microbiome control. Neither cited experiment demonstrates removal of a mature polymicrobial biofilm. [1][2][3]
Exposure & chemical form
The mixed-ligand study varied bacterial-assay pH from 5 to 8 and measured aqueous speciation. Its evidence for lower-pH activation in cancer cells must not be transferred automatically to bacterial infections. The chemical form present in the assay needs measurement. [2]
What the evidence does not establish
The evidence remains early and compound-specific. Cytotoxic activity in cancer-cell models establishes biological potency, not selectivity for bacteria over normal human tissue. Suitable host-cell comparisons, stability in biological fluids, and infection models are still needed to interpret an antibacterial hit as a therapeutic candidate. [1][2][3]
Open research questions
Questions suggested by the evidence and its limits.
Selected research
Sources supporting the numbered statements and study summaries above. Publication status is identified where a source reports trial results outside a peer-reviewed paper. This is a curated entry point, not a systematic review.
- Marco A, Vigueras G, Busto N, Cutillas N, Bautista D, Ruiz J (2023). Novel valproate half-sandwich rhodium and iridium conjugates to fight against multidrug-resistant Gram-positive bacteria. View source↩↩↩↩↩↩
- Mészáros JP, Kandioller W, Spengler G, Prado-Roller A, Keppler BK, Enyedy ÉA (2023). Half-Sandwich Rhodium Complexes with Releasable N-Donor Monodentate Ligands: Solution Chemical Properties and the Possibility for Acidosis Activation. View source↩↩↩↩↩↩↩
- Balázs B, Tóth Z, Kacsir I, Sipos A, Buglyó P, Somsák L, Bokor É, Kardos G, Bai P (2022). Targeting Multiresistant Gram-Positive Bacteria by Ruthenium, Osmium, Iridium and Rhodium Half-Sandwich Type Complexes With Bidentate Monosaccharide Ligands. View source↩↩↩↩